-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Our Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Career Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
WHITE PAPER
The Case for Healthcare Reform in Emerging Southeast Asia
A perspective on healthcare financing reform and how it can be applied to Southeast Asia
May 31, 2022
Southeast Asia's (SEA) healthcare financing systems have been managed well thus far but there remain gaps with the unsustainable pace in which healthcare needs and costs are growing. In the last decade, SEA has experienced rapid changes, driven by aging populations and increasing life expectancy. Coupled with shifting disease burden towards chronic non-communicable disease, the demand for healthcare has increased substantially.
Yet this rise in demand has not been proportionately matched by government spending on health with concerns over straining public funds. Expenditure remains at an average of 4-5% of total GDP across Southeast Asia, below the global average of 6-7%, and well below the OECD markets average of ~13%. Will the current system be sufficient to manage the growing healthcare demands and overcome the challenges of healthcare financing within the region?
This whitepaper will highlight the obstacles SEA nations face in their past attempts for healthcare financing reform, successful case studies of Europe and North America as well as approaches SEA nations can adopt to overcome this long-standing problem.
To find out more about healthcare financing in Southeast Asia, please contact us.
Authors
- Jisu Kim, Consultant, Consulting Services, IQVIA APAC
- Devaraj Subramaniam, Associate Principal, Consulting Services, IQVIA APAC
- Nikhil Khicha, Senior Principal, Consulting Services, IQVIA APAC